19-Nor-10-azasteroids: A novel class of inhibitors for human steroid 5α-reductases 1 and 2

Journal of Medicinal Chemistry

Volumn 40, Issue 7, 1997, Pages 1112-1129

  Guarna, Antonio ^a   Belle, Catherine ^a,b   Machetti, Fabrizio ^a   Occhiato, Ernesto G ^a   Payne, Andrew H ^a,c   Cassiani, Chiara ^a   Comerci, Alessandra ^a   Danza, Giovanna ^a   De Bellis, Alessandra ^a   Dini, Stefania ^a   Marrucci, Alessandro ^a   Serio, Mario ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIV GRENOBLE ALPES   (France)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

17BETA (N TERT BUTYLCARBAMOYL) 19 NOR 10 AZA 4 ANDROSTEN 3 ONE; FINASTERIDE; STEROID 5ALPHA REDUCTASE INHIBITOR; UNCLASSIFIED DRUG;

ACNE; ALOPECIA; ARTICLE; DRUG ACTIVITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HIRSUTISM; HUMAN; MALE TYPE ALOPECIA; PROSTATE CANCER; PROSTATE HYPERTROPHY;

AZASTEROIDS; ENZYME INHIBITORS; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MASS SPECTROMETRY; PROSTATIC NEOPLASMS; TESTOSTERONE 5-ALPHA-REDUCTASE; TUMOR CELLS, CULTURED;

EID: 2642697958     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960807v     Document Type: Article

References (80)

1. (a) Russell, D. W.; Wilson, J. D. Steroid 5α-Reductases: Two Genes/Two Enzymes. Annu. Rev. Biochem. 1994, 63, 25-61.
2. (b) Wilson, J. D.; Griffin, J. E.; Russell, D. W. Steroid 5α-Reductase 2 Deficiency. Endocrine Rev 1993, 14, 577-593.
3. Rasmusson, G. H. Chemical Control of Androgen Action. Annu. Rep. Med. Chem. 1986, 22, 179-188.
4. Geller, J. Benign Prostatic Hyperplasia: Pathogenesis and Medical Therapy. J Am. Geriatr. Soc. 1991, 39, 1208-1266.
5. (a) Gormley, G. J. Role of 5α-Reductase Inhibitors in the Treatment of Advanced Prostatic Carcinoma. Urol. Clin. North Am. 1991, 18, 93-98.
6. (b) Brawley, O. W.; Ford, G. L.; Thompson, I.; Perlman, J. A.; Kramer, B. S. 5α-Reductase Inhibition and Prostate Cancer Prevention. Cancer Epidemiol. Biomarkers Prev. 1994, 3, 177-182.
7. Dallob, A. L.; Sadick, N. S.; Unger, W.; Lipert, S.; Geissler, L. A.; Gregoire, S. L.; Nguyen, H. H.; Moore, E. C.; Tanaka, W. K. The Effect of Finasteride, a 5α-Reductase Inhibitor, on Scalp Skin Testosterone and Dihydrotestosterone Concentrations in Patients with Male Pattern Baldness. J. Clin. Endocrinol. Metab. 1994, 79, 703-706.
8. Smith, L. S.; Tegler, J. J. Advances in Dermatology. Annu. Rep. Med. Chem. 1989, 24, 177-186.
9. Gadwood, R. C.; Fiedler, V. C. Pathogenesis and Treatment of Alopecias. Annu. Rep. Med. Chem. 1989, 24, 187-196.
10. Brooks, J. R. Treatment of Hirsutism with 5α-Reductase Inhibitors. Clin. Endocrinol. Metabol. 1986, 15, 391-405.
11. Metcalf, B. W.; Levy, M. A.; Holt, D. A. Inhibitors of Steroid 5α-Reductase in Benign Prostatic Hyperplasia, Male Pattern Baldness and Acne. Trends Pharmacol. Sci. 1989, 10, 491-495.
12. (a) Holt, D. A.; Levy, M. A.; Metcalf, B. W. Inhibition of Steroid 5α-Reductase. In Advances in Medicinal Chemistry; Maryanoff, B. E., Maryanoff, C. A., Eds.; JAI Press Inc.: Greenwich, CT, 1993; Vol. 2, pp 1-29.
13. (b) Abell, A. D.; Henderson, B. R. Steroidal and Non-Steroidal Inhibitors of Steroid 5α-Reductase. Curr. Med. Chem. 1995, 2, 583-597.
14. (c) Li, X.; Chen, C.; Singh, S.; Labrie, F. The Enzyme and Inhibitors of 4-Ene-3-oxosteroid 5α-Oxidoreductase. Steroids 1995, 60, 430-441.
15. (a) Geller, J. Effect of Finasteride, a 5α-Reductase Inhibitor on Prostate Tissue Androgens and Prostate-Specific Antigen. J. Clin. Endocrinol. Metab. 1990, 71, 1552-1555.
16. (b) Stoner, E. The Clinical Development of a 5α-Reductase Inhibitor, Finasteride. J. Steroid Biochem. Mol. Biol. 1990, 37, 375-378.
17. (c) Gormley, G. J.; et al. The Effect of Finasteride in Men with Benign Prostatic Hyperplasia. New Engl. J. Med. 1992, 327, 1185-1191.
18. (a) Rasmusson, G. H.; Reynolds, G. F.; Utne, T.; Jobson, R. B.; Primka, R. L.; Berman, C.; Brooks, J. R. Azasteroids as Inhibitors of Rat Prostatic 5α-Reductase. J. Med. Chem. 1984, 27, 1690-1701.
19. (b) Rasmusson, G. H.; Reynolds, G. F.; Steinberg, N. G.; Walton, E.; Patel, G. F.; Liang, T.; Cascieri, M. A.; Cheung, A. H.; Brooks, J. R.; Berman, C. Azasteroids: Structure-Activity Relationships for Inhibition of 5α-Reductase and of Androgen Receptor Binding. J. Med. Chem. 1986, 29, 2298-2315.
20. (c) Mellin, T. N.; Busch, R. D.; Rasmusson, G. H. Azasteroids as Inhibitors of Testosterone 5α-Reductase in Mammalian Skin. J. Steroid Biochem. Mol. Biol. 1993, 44, 121-131.
21. (d) Bakshi, R. K.; Patel, G. F.; Rasmusson, G. H.; Baginsky, W. F.; Cimis, G.; Ellsworth, K.; Chang, B.; Bull, H.; Tolman, R. L.; Harris, G. S. 4,7β-Dimethyl-4-azacholestan-3one (MK-386) and Related 4-Azasteroids as Selective Inhibitors of Human Type 1 5α-Reductase. J. Med. Chem. 1994, 37, 3871-3874.
22. (a) Levy, M. A.; Brandt, M.; Sheedy, K. M.; Dinh, J. T.; Holt, D. A.; Garrison, L. M.; Bergsma, D. J.; Metcalf, B. W. Epristeride is a Selective and Specific Uncompetitive Inhibitor of Human Steroid 5α-Reductase Isoform 2. J. Steroid Biochem. Mol. Biol. 1994, 48, 197-206.
23. (b) Audet, P.; Nurcombe, H.; Lamb, Y.; Yorkasky, D.; Loyd-Davies, K.; Morris, R. Effect of Multiple Doses of Epristeride, a Steroid 5α-Reductase Inhibitor, on Serum Dihydrotestosterone in Older Male Subjects. Clin. Pharmacol. Ther. 1993, 53, 231.
24. (c) Baine, N. H.; Owings, F. F.; Kline, D. N.; Resnick, T.; Ping, L.; Fox, M.; Mewshaw, R. E.; Tickner, A. M.; Kowalski, C. J. Improved Synthesis of Epristeride, a Potent Human 5α-Reductase Inhibitor. J. Org. Chem. 1994, 59, 5987-5989.
25. (a) Holt, D. A.; Levy, M. A.; Oh, H.; Erb, J. M.; Heaslip, J. I.; Brandt, M.; Lan-Hargest, H.; Metcalf, B. W. Inhibition of Steroid 5α-Reductase by Unsaturated 3-Carboxysteroids J. Med. Chem. 1990, 33, 943-950.
26. (b) Levy, M. A.; Brandt, M.; Heys, J. R.; Holt, D. A.; Metcalf, B. W. Inhibition of Rat Liver Steroid 5α-Reductase by 3-Androstene-3-carboxylic Acid: Mechanism of Enzyme-Inhibitor Interaction. Biochemistry 1990, 29, 2815-2824.
27. (a) Rittmaster, R. S. Drug Therapy: Finasteride. New Engl. J. Med. 1994, 330, 120-125.
28. (b) Rittmaster, R. S.; Antonian, L.; New, M. I.; Stoner, E. Effect of Finasteride on Adrenal Steroidogenesis in Men. J. Androl. 1994, 15, 298-301.
29. (a) Frye, S. V.; Haffner, C. D.; Maloney, P. R.; Mook, R. A., Jr.; Dorsey, G. F., Jr.; Hiner, R. N.; Batchelor, K. W.; Bramson, H. N.; Stuart, J. D.; Schweiker, S. L.; Van Arnold, J.; Bickett, D. M.; Moss, M. L.; Tian, G.; Unwalla, R. J.; Lee, F. W.; Tippin, T, K.; James, M. K.; Grizzle, M. K.; Long, J. E.; Schuster, S. V. 6-Azasteroids: Potent Dual Inhibitors of Human Type 1 and 2 Steroid 5α-Reductase. J. Med. Chem. 1993, 36, 4313-4315.
30. 5-Steroid Isomerase. J. Med. Chem. 1994, 37, 2352-2360.
31. (a) Rittmaster, R. S.; Uno, H.; Povar, M. L.; Mellin, T. N.; Loriaux, D. L. The Effects of N,N-Diethyl-4-Methyl-3-Oxo-4-Aza-5α-Androstane-17β-Carboxamide, a 5α-Reductase Inhibitor and Antiandrogen, on the Development of Baldness in the Stumptail Macaque. J. Clin. Endocrinol. Metab. 1987, 65, 188-193.
32. (b) Thiboutot, D.; Harris, G.; Iles, V.; Cimis, G.; Gilliland, K.; Hagari, S. Activity of the Type 1 5α-Reductase Exhibits Regional Differences in Isolated Sebaceous Glands and Whole Skin. J. Invest. Dermatol. 1995, 105, 209-214.
33. (c) Mestayer, C.; Berthaut, I.; Portois, M. C.; Kuttenn, W. F.; Mowszowicz, I.; Mauvais-Jarvis, P. Comment: Predominant Expression of 5α-Reductase Type 1 in Pubic Skin from Normal Subjects and Hirsute Patients. J. Clin. Endocrinol. Metab. 1996, 81, 1989-1993.
34. Gormley, G. J. Finasteride: a Clinical Review. Biomed. Pharmacother. 1995, 49, 319-324.
35. Guarna, A.; Marrucci, A.; Danza, G.; Serio, M, Relationship Between Structure and Activity of 5α-Reductase Inhibitors. In Sex Hormones and antihormones in endocrine dependent pathology: basic and clinical aspects; Motta, M., Serio, M., Eds.; Elsevier Science B.V.: Amsterdam, The Netherlands, 1994.
36. (a) Guarna, A.; Brandi, A.; De Sarlo, F.; Goti, A.; Pericciuoli, F. Rearrangement of Isoxazoline-5-Spiro Derivatives. 1. Synthesis of 4,5-Dihydroisoxazole-5-spirocyclopropanes and Their Rearrangement to 5,6-Dihydro-4-pyridones. J. Org. Chem. 1988, 53, 2426-2429.
37. (b) Brandi, A.; Cordero, F. M.; De Sarlo, F.; Goti, A.; Guarna, A. New Synthesis of Azaheterocycles by Rearrangement of Isoxazoline-5-Spirocycloalkane Compounds. Synlett 1993, 1-8.
38. Dapporto, P.; Paoli, P.; Brandi, A.; De Sarlo F.; Goti, A.; Guarna, A. 5-Spirocycloalkane Isoxazolines: Structures and Thermal Behaviour. Acta Crystallogr. 1992, B48, 234-238.
39. Occhiato, E.; Guarna, A.; Brandi, A.; Goti, A.; De Sarlo, F. N-Bridgehead Polycyclic Compounds by Sequential Rearrangement-Annulation of Isoxazoline-5-Spirocyclopropanes. 6. A General Synthetic Method for 5,6-Dihydro-7(8H)-and 2,3,5,6-Tetrahydro-7(1H)-indolizinones. J. Org. Chem. 1992, 57, 4206-4211.
40. 9(11)-19-Nor-10-Aza-Testosterone. Tetrahedron Lett. 1991, 32, 6395-6398.
41. Belle, C.; Guarna, A.; Paoli, P.; Dapporto, P. New Aspects of the Catalytic Hydrogenation of 2,3,5,6,7,7a-Hexahydro-1β-hydroxy-7aβ-methyl-5-oxo-1H-indene-4- Propionic Acid, an Important Intermediate in the Total Synthesis of Steroids. J. Chem. Res. 1992, 122-123.
42. Biggs, C. B.; Pyke, T. R.; Wovcha, M. G. (Upjhon Co.). U.S. Pat. 4 062 729, 1977; Chem. Abstr. 1978, 88, 188129t.
43. Biggs, C. B.; Pyke, T. R.; Wovcha, M. G. (Upjhon Co.). U.S. Pat. 4 062 729, 1977; Chem. Abstr. 1978, 88, 188129t.
44. Edward, B. E.; Rao, P. N. Perchloric Acid Catalyzed Acetylations. Enol Lactonization and Enol Acetylation of Steroids. J. Org. Chem. 1966, 3, 324-327.
45. Komeno, T.; Ishihara, S.; Itani, H. Thiosteroids-XXXIH 10β-Methylsulfonyl and 10β-Phenylsulfonyl Des-A-Estr-9(11)-ene Derivatives and Their Alkylation Reaction: Synthesis of A-Furanosteroids. Tetrahedron 1972, 28, 4719-4736.
46. (a) Stang, P. J.; Fisk, T. E. Synthesis of 1-(Ethynyl)-vinyl Trifluoromethansulfonates. Synthesis 1979, 438-440.
47. (b) Cacchi, S.; Morera, E.; Ortar, G. Palladium-catalyzed Carbonylation of Enol Triflates. A Novel Method for One-Carbon Homologation of Ketones to α,β-Unsaturated Carboxylic Acid. Tetrahedron Lett. 1985, 26, 2965, 2966.
48. Huet, F.; Lechevallier, A.; Pellet, M.; Conia, J. M. Wet Silica Gel; a Convenient Reagent for Deacetylization. Synthesis 1979, 725.
49. Lee, G. A. A Simplified Synthesis of Unsaturated Nitrogen-Heterocycles using Nitrile Betaines. Synthesis 1982, 508.
50. Cherest, M.; Felkin, H. The Influence of Steric and Torsional Strain on the Steric Course of Additions to Cyclohexanones. The Reaction between 4-t-Butylcyclohexanone and t-Butylallyl Magnesium Bromide. Tetrahedron Lett. 1971, 383.
51. Results presented at the Second European Congress of Pharmaceutical Sciences, Berlin, Germany, Sept. 29-Oct 1, 1994. Guarna, A.; Marrucci, A.; Danza, G.; Serio, M. Structure-Activity Relationship of Inhibitors for Steroid 5α-Reductase. Eur. J. Pharm. Sci. 1994, 2, 91.
52. Results presented at the Second European Congress of Pharmaceutical Sciences, Berlin, Germany, Sept. 29-Oct 1, 1994. Guarna, A.; Marrucci, A.; Danza, G.; Serio, M. Structure-Activity Relationship of Inhibitors for Steroid 5α-Reductase. Eur. J. Pharm. Sci. 1994, 2, 91.
53. Oechiato, E. G.; Guarna, A.; Spinetti, L. M. Enantioselective Synthesis of Indolizine Derivatives by Rearrangement-Cyclization of Isoxazoline-5-spirocyclopropanes. Tetrahedron 1993, 49, 10629-10642 and references cited therein.
54. (a) Crabb, T. A.; Newton, R. F.; Jackson, D. Stereochemical Studies of Nitrogen Bridgehead Compounds by Spectral Means. Chem. Rev. 1971, 71, 109-126.
55. (b) Wilson, S. R.; Sawicki, R. A. Stereochemistry, Conformational Analysis and Transannular Cyclisation of Nine-Membered Ring Azaolefins. J. Org. Chem. 1979, 44, 330-336.
56. 1(10)-Dehydroquinolizidines. J. Am. Chem. Soc. 1955, 77, 439-444.
57. Bertin, D.; Perronet, J. Synthèse de Stéroides Hétérocycliques. L'Aza-10 nor-19 Testostérone de Configuration Naturelle. (Synthesis of Heterocycle Steroids. 19-Nor-10-aza-Testosterone with Natural Configuration.) Bull. Soc. Chim. (France) 1969, 117-122.
58. (a) Liang, T.; Cascieri, M. A.; Cheung, A. H.; Reynolds, G. F.; Rasmusson, G. H. Species Differences in Prostatic Steroid 5α-Reductases of Rat, Dog, and Human. Endocrinology 1985, 117, 571-579.
59. 4-3-Ketosteroid (5α) Reductase Inhibitors. Chem. Pharm. Bull. 1989, 37, 3128-3130.
60. Program kindly furnished by A. De Lean, P. J. Munson, V. Guardabasso, D. Rodbard. Laboratory of Theoretical and Physical Biology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892.
61. (a) Bruchovsky, N.; Rennie, P. S.; Batzold, F. K.; Goldenberg, S. L.; Fletcher, T.; McLoughlin, M. G. Kinetic Parameters of 5α-Reductase Activity in Stroma and Epithelium of Normal, Hyperplastic and Carcinomatous Human Prostates. J. Clin. Endocrinol. Metab. 1988, 67, 806-816.
62. (b) Houston, B.; Chisholm, G. D.; Habib, F. K. A Kinetic Analysis of the 5α-Reductases from Human Prostate and Liver. Steroids 1987, 49, 355-369.
63. (c) Quemener, E.; Amet, Y.; di Stefano, S.; Fournier, G.; Floch, H. H.; Abalain, J. H. Purification of Testosterone 5α-Reductase from Human Prostate by a Four-Step Chromatographic Procedure. Steroids 1994, 59, 712-718.
64. Span, P. N.; Benraad, T. J.; Sweep, C. G. J.; Smals, A. G. H. Kinetic Analysis of Steroid 5α-Reductase Activity at Neutral pH In Benign Prostatic Hyperplastic Tissue: Evidence for Type I Isoenzyme Activity in the Human Prostate. J. Steroid Biochem. Mol. Biol. 1996, 57, 103-108.
65. 37a,44,48 For a recent comparison of finasteride inhibition potency toward types 1 and 2 isozymes expressed in a different system, see ref 48.
66. Weisser, H.; Tunn, S.; Debus, M.; Krieg, M. 5α-Reductase Inhibition by Finasteride (Proscar) in Epithelium and Stroma of Human Benign Prostatic Hyperplasia. Steroids 1994, 59, 616-620.
67. Delos, S.; Carsol, J.-L.; Ghazarossian, E.; Raynaud, J.-P.; Martin, P.-M. Testosterone Metabolism in Primary Cultures of Human Prostate Epithelial Cells and Fibroblasts. J. Steroid Biochem. Mol. Biol. 1995, 55, 375-383.
68. Andersson, S.; Berman, D. M.; Jenkins, E. P.; Russell, D. W. Deletion of Steroid 5α-Reductase 2 Gene in Male Pseudohermaphroditism. Nature (London) 1991, 354, 159-161.
69. Jenkins, E. P.; Andersson, S.; Imperato-McGinley, J.; Wilson, J. D.; Russell, D. W. Genetic and Pharmacological Evidence for More Than One Human Steroid 5α-Reductase. J. Clin. Invest. 1992, 89, 293-300.
70. Thigpen, A. E.; Cala, K. M.; Russell, D. W. Characterization of Chinese Hamster Ovary Cell Lines Expressing Human Steroid 5α-Reductase Isozymes. J. Biol. Chem. 1993, 268, 17404-17412.
71. Iehle, C.; Delos, S.; Guirou, O.; Tate, R.; Raynaud, J.-P.; Martin, P.-M. Human Prostatic Steroid 5α-Reductase Isoforms - A Comparative Study of Selective Inhibitors. J. Steroid Biochem. Mol. Biol. 1995, 54, 273-279.
72. Smith, C. M.; Ballard, S. A.; Worman, N.; Buettner, R.; Masters, J. R. W. 5α-Reductase Expression by Prostate Cancer Cell Lines and Benign Prostatic Hyperplasia in Vitro. J. Clin. Endocrinol. Metab. 1996, 81, 1361-1366.
73. Delos, S.; Iehlé, C.; Martin, M.; Raynaud, J.-P. Inhibition of the Activity of 'Basic' 5α-Reductase (Type 1) Detected in DU 145 Cells and Expressed in Insect Cells. J. Steroid Biochem. Mol. Biol. 1994, 48, 347-352.
74. Kaefer, M.; Audia, J. E.; Bruchovsky, N.; et al. Characterization of Type I 5α-Reductase Activity in DU145 Human Prostatic Adenocarcinoma Cells. J. Steroid Biochem. Mol. Biol. 1996, 58, 195-205.
75. Li, X.; Singh, S. M.; Labrie, F. Synthesis and in Vitro Activity of 17β-(N-Alkyl/arylformamido) and 17β-(N-alkyl/arylalkyl/arylamido)-4-methyl-4-aza-3-oxo-5α-androstan- 3-ones as Inhibitors of Human 5α-Reductases and Antagonists of the Androgen Receptor. J. Med. Chem. 1995, 38, 1158-1173.
76. Wolfenden, R. Analog Approaches to the Structure of the Transition Sate in Enzyme Reactions. Acc. Chem. Res. 1972, 5, 10-18.
77. Bull, H. G.; Garcia-Calvo, M.; Andersson, S.; et al. Mechanism-Based Inhibition of Human Steroid 5α-Reductase by Finasteride: Enzyme-Catalyzed Formation of NADP-Dihydrofinasteride, a Potent Bisubstrate Analog Inhibitor. J. Am. Chem. Soc. 1996, 118, 2359-2365.
78. Li, X.; Singh, S. M.; Luu-The, V.; Côté, J.; Laplante, S.; Labrie, F. Vinyl Fluoride as a Mimic of the 'Intermediate' Enol Form In The 5α-Reductase Transformation: Synthesis and in Vitro Activity of (N-1′,1′-Dimethylethyl)-3-haloandrosta-3,5-diene-17β- Carboxamides. Bioorg. Med. Chem. 1996, 4, 55-60.
79. HF-STO3-21G* basis set calculations were performed by using the program SPARTAN, version 3.1, Wavefunction Inc., 18401 Von Karman Ave, 370, Irvine, CA 92715.
80. 8(9)-19-nor-10-azasteroids are quite flexible molecules having four low-energy conformers within the 3 kcal/mol range above the global energy minimum.